Clemenger BBDO Sydney wins the creative account for Demazin
INova Pharmaceuticals’ Demazin has awarded its creative account to Clemenger BBDO Sydney, following a competitive three-way pitch.
The agency will immediately begin work on relaunching the brand, briefed with finding a disruptive way to refresh and modernise its marketing. Clemenger BBDO Sydney will aim to make Demazin relevant to a new generation of parents.
Clemenger BBDO Sydney has been tasked with refreshing the Demazin brand
Whilst partaking in the pitch, Clemenger BBDO Sydney undertook qualitative research to discover what parents look for in a cold and flu brand.
Filomena Maiese, executive director of portfolio strategy and innovation at iNova Pharmaceuticals, said: “The challenge we put to the agencies through the pitch process was to make the Demazin brand relevant to modern day mums and families in a disruptive way. Clemenger went the extra mile to really understand the insights around our consumer to develop a campaign idea that would resonate with our audience in a fresh and relevant way.
“We are really excited to bring this campaign to market with Clemenger. It will definitely break category conventions in a category that has become quite conventional and formulaic in its consumer advertising approach.”
Pete Bosilkovski, CEO Clemenger BBDO Sydney, said: “We are thrilled to be working on the iconic Demazin brand, and I think we all have fond memories of D-D Demazin. It’s always exciting to work with client partners who share our passion and obsessive focus on consumer centricity, together with relentless empathy for the needs of the consumer.
“We look forward to collaborating with the amazing team at iNova to drive the Demazin brand forward and bring it back to its former glory.”
